Delivery Order SPE2DB24D2106-SPE2DB25FAVAG
Award Date
4/15/25
Potential Completion Date
5/6/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,135.35 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This federal contract award is a $4,417.24 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4567199030 - PROMACTA 12.5 MG TABLET UU 30S, a specialized pharmaceutical product, with a period of performance through February 28, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $4,418.06 and has an ultimate completion date of July 10, 2025. It covers the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. has a significant single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of 4,568,160,321 units of the prescription drug Promacta 25 mg tablets. The contract has an ultimate completion date of May 28, 2025 and was awarded on May 6, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,418.06, is for the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc....
This federal contract award is a delivery order valued at $8,835.30 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the provision of PROMACTA 25 MG TABLET, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $21,727.74 contract is for the delivery of PROMACTA 50 MG TABLET, a branded pharmaceutical product, with a period of performance ending April 3, 2024. DMS Pharmaceutical Group holds a separate $4,999,999 indefinite-delivery, indefinite-quantity (IDIQ) contract with DLA to provide a broad range of...
This federal contract award, valued at $3,997.21, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order with no set-aside designation, falling under the DLA's SPE2DB program, which is a $499,999,999 indefinite delivery contract that covers a wide range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,026.53, is for the delivery of PROMACTA 50 MG TABLET UU 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. The contract has a completion date of February 19, 2025 and is not associated with any set-aside designation. DMS...
This is a delivery order award under contract SPE2DB24D2106 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $21,727.74 firm fixed-price contract is with the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including PROMACTA 50 mg tablets. This award is not associated with any set-aside program. DMS Pharmaceutical Group holds an indefinite delivery contract, SPE2DB24FATWX, with DLA valued up to $4,999,999 through 2025...